1. Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study. (22nd February 2017) Authors: Sandborn, William J.; Rutgeerts, Paul; Colombel, Jean-Frédéric; Ghosh, Subrata; Petryka, Robert; Sands, Bruce E.; Mitra, Pranab; Luo, Allison Journal: Journal of Crohn's and colitis Issue: Volume 11:Number 7(2017:Jul.) Page Start: 811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗